We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Psychostimulant Abuse - Novel Treatment Approaches - 1

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00000325
First Posted: September 21, 1999
Last Update Posted: January 12, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Mclean Hospital
Information provided by:
National Institute on Drug Abuse (NIDA)
  Purpose
To determine if acute assessments of profasi and factrel affect plasma cocaine levels and cocaine-induced behavioral changes in men.

Condition Intervention Phase
Cocaine-Related Disorders Behavioral: Gonadorelin Phase 1

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Psychostimulant Abuse - Novel Treatment Approaches

Resource links provided by NLM:


Further study details as provided by National Institute on Drug Abuse (NIDA):

Estimated Enrollment: 0
Estimated Study Completion Date: December 2001
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Criteria
Please contact site for information.
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00000325


Locations
United States, Massachusetts
McLean Hospital, Dept. of Psychiatry
Belmont, Massachusetts, United States, 2178
Sponsors and Collaborators
National Institute on Drug Abuse (NIDA)
Mclean Hospital
Investigators
Principal Investigator: Jack Mendelson, M.D. Mclean Hospital
  More Information

ClinicalTrials.gov Identifier: NCT00000325     History of Changes
Other Study ID Numbers: NIDA-10757-1
R01-10757-1
First Submitted: September 20, 1999
First Posted: September 21, 1999
Last Update Posted: January 12, 2017
Last Verified: December 2002

Keywords provided by National Institute on Drug Abuse (NIDA):
cocaine dependence

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders